277 related articles for article (PubMed ID: 32641783)
1. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil.
Silveira MF; Barros AJD; Horta BL; Pellanda LC; Victora GD; Dellagostin OA; Struchiner CJ; Burattini MN; Valim ARM; Berlezi EM; Mesa JM; Ikeda MLR; Mesenburg MA; Mantesso M; Dall'Agnol MM; Bittencourt RA; Hartwig FP; Menezes AMB; Barros FC; Hallal PC; Victora CG
Nat Med; 2020 Aug; 26(8):1196-1199. PubMed ID: 32641783
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.
Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL;
Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2.
Guedez-López GV; Alguacil-Guillén M; González-Donapetry P; Bloise I; Tornero-Marin C; González-García J; Mingorance J; García-Rodríguez J;
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2289-2297. PubMed ID: 32808111
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
7. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
8. Serosurvey of SARS-CoV-2 among hospital visitors in China.
Liang W; Lin Y; Bi J; Li J; Liang Y; Wong SS; Zanin M; Yang Z; Li C; Zhong R; Jiang G; Han G; Hu D; He J; Zhong N
Cell Res; 2020 Sep; 30(9):817-818. PubMed ID: 32686766
[No Abstract] [Full Text] [Related]
9. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood.
Wang Z; Zheng Z; Hu H; Zhou Q; Liu W; Li X; Liu Z; Wang Y; Ma Y
Lab Chip; 2020 Nov; 20(22):4255-4261. PubMed ID: 33064114
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
[TBL] [Abstract][Full Text] [Related]
13. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
14. Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.
Sutton M; Cieslak P; Linder M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1100-1101. PubMed ID: 32790658
[No Abstract] [Full Text] [Related]
15. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.
Fischer B; Knabbe C; Vollmer T
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700672
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.
Xu X; Sun J; Nie S; Li H; Kong Y; Liang M; Hou J; Huang X; Li D; Ma T; Peng J; Gao S; Shao Y; Zhu H; Lau JY; Wang G; Xie C; Jiang L; Huang A; Yang Z; Zhang K; Hou FF
Nat Med; 2020 Aug; 26(8):1193-1195. PubMed ID: 32504052
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
[TBL] [Abstract][Full Text] [Related]
20. Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and perspectives.
Vieira MADCES; Vieira CPB; Borba AS; Melo MCC; Oliveira MS; Melo RM; Nunes VV; Santana WS; Aguiar YA
Rev Soc Bras Med Trop; 2020; 53():e20200351. PubMed ID: 32638891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]